Bicycle Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.

About BCYC

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles.

CEO

Kevin Lee

CEOKevin Lee

Employees

119

Employees119

Headquarters

Cambridge, Cambridgeshire

HeadquartersCambridge, Cambridgeshire

Founded

2009

Founded2009

Employees

119

Employees119

BCYC Key Statistics

Market cap

692.34M

Market cap692.34M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

200.71K

Average volume200.71K

High today

$24.39

High today$24.39

Low today

$23.19

Low today$23.19

Open price

$23.76

Open price$23.76

Volume

166.18K

Volume166.18K

52 Week high

$62.08

52 Week high$62.08

52 Week low

$12.08

52 Week low$12.08

Analyst ratings

86%

of 14 ratings

Buy

85.7%

Hold

14.3%

Sell

BCYC Earnings

-$0.93

-$0.62

-$0.31

-$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 3, Pre-Market

ActualExpected Nov 3, Pre-Market